Skye Bioscience (NASDAQ: SKYE) is a micro-cap pharmaceutical company that is striving to become the next big thing in the ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Popular weight-loss drugs like Ozempic are used to treat obesity and diabetes. Now, researchers found that these drugs also ...

Questor is The Telegraph’s stockpicking column, helping you decode the markets and offering insights on where to invest for ...

A recent research published in the Food Bioscience journal highlighted an critical connection between Type 2 taste receptors ...

A highly effective class of weight loss drug has taken the world by storm, as medications like Ozempic, Wegovy, and Zepbound ...

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC / ACCESSWIRE / October 9, ...

The 2024 increase is the same as last year.The foundation’s annual survey of employer health benefits also found that only 18 ...

American adults prefer dietary change as a weight loss method, over injectable weight loss drugs such as Ozempic, a survey says.

A large study of veterans with type 2 diabetes finds better short-term kidney outcomes with use of SGLT2 inhibitors vs GLP-1 receptor agonists.

Doctors have issued a serious health warning over the extremely dangerous ‘faux-zempic’ as the weight loss drugs see an ...

Adults with type 2 diabetes using metformin had a slightly lower risk of dying or developing long COVID within 180 days after ...